---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-004669"
form_type: "8-K"
ticker: "MODD"
cik: "0001074871"
company_name: "Modular Medical, Inc."
filed_at: "2024-01-19T23:59:59+00:00"
generated_at: "2026-06-06T20:59:21.742131+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Modular Medical submits MODD1 insulin pump to FDA for 510(k) clearance

## Summary
- Submitted MODD1 next-generation insulin pump to FDA for 510(k) clearance on Jan 19, 2024.
- Expects initial FDA questions during quarter ending June 30, 2023 (as stated in press release).
- Plans to file for UKCA mark to market MODD1 in the United Kingdom.
- CEO Jeb Besser and Chairman Paul DiPerna highlighted simplified design to boost pump adoption.

## SEC filing metadata
- accession: 0001213900-24-004669
- form_type: 8-K
- ticker: MODD
- cik: 0001074871
- company_name: Modular Medical, Inc.
- filed_at: 2024-01-19T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1074871/000121390024004669/0001213900-24-004669-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1074871/000121390024004669/ea191833-8k_modular.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-004669
- JSON: https://secwatch.observer/filing/0001213900-24-004669.json
- Plain text: https://secwatch.observer/filing/0001213900-24-004669.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.